Showing 51-60 of 1135 results for "".
Aubio Launches, Updates from Prescriber's Choice, BioPharmX
https://practicaldermatology.com/topics/practice-management/dermwiretv-aubio-launches-updates-from-prescriber-s-choice-biopharmx/18584/In this edition of DermWireTV, Aubio launches OTC treatment for cold sores with backing from Paul Mitchell partner. Prescriber's Choice facilitates in-office prescription dispensing. BioPharmX enrolls phase 2b trial for topical minocycline and Merz acquires ONLight Sciences, maker of PFD patch for tRestylane Silk Launches; Xeljanz to FDA
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-restylane-silk-launches-xeljanz-to-fda/18970/This edition of DermWireTV covers the launch of Restylane Silk from Galderma for the treatment of lips and FDA acceptance of the NDA for Pfizer's Xeljanz (tofacitinib) for adults with psoriasis. Plus, new data from the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) show incrTECHtonic Shifts: Big Data, AI, and Dermatology
https://practicaldermatology.com/topics/practice-management/techtonic-shifts-big-data-ai-and-dermatology/18428/Robots can diagnose skin malignancies. Big data may give insurers ammunition to reduce payments. And dermatologists are left dealing with the fall-out from the rapid evolution of technology. In this special edition of Derm Insider Mark Kaufmann, MD dives into the challenges facing the specialty andAdult Female Acne: Step by Step
https://practicaldermatology.com/topics/general-topics/adult-female-acne-step-by-step/18462/With many effective options available to treat adult female acne, management can seem like a daunting task. In this edition of DermTube Journal Club, Bethanee Schlosser, MD talks to host Joshua Zeichner, MD, about aspects of care from assessment to treatment, with an emphasis on identifying the bestDerm Insider: Ethics and Industry: How to Manage Relationships with Pharma
https://practicaldermatology.com/topics/practice-management/derm-insider-ethics-and-industry-how-to-manage-relationships-with-pharma/19029/In this edition, host Neal Bhatia, MD and guests Tom Prunty and James Q. Del Rosso, DO tackle the ethics of industry relationships. They discuss the nuances and challenges of physicians fostering appropriate relationships with pharmaceutical manufacturers amid an increasingly stringent regulatory laBiologics Preferred after MACE in PsO, Plus More
https://practicaldermatology.com/series/dermwire-tv/biologics-preferred-after-mace-in-pso-plus-more/37882/In this edition of DermwireTV, new research shows biologic use use after MACE is persistent, signaling strong patient preference; a new study shows that early stress may raise lifelong psoriasis risk; and a new C-Suite Chat highlights a new antibody showing promise in treating atopic dermatitisItching for Answers: Understanding and Treating Pruritus
https://practicaldermatology.com/topics/general-topics/itching-for-answers-understanding-and-treating-pruritus/18493/Since childhood, when he was affected by eczema and associated pruritus, Ethan Lerner, MD, PhD has been fascinated by itch, its causes, and its potential treatments. In this edition of Benchside Dispatches, he offers a fresh look at the latest research on pruritus and the challenges facing scientistDefining the Physician-Patient Relationship
https://practicaldermatology.com/topics/practice-management/defining-the-physician-patient-relationship/18928/In this edition of Derm Insider, Allan Wirtzer, MD and Cliff Lober, MD, JD talk to host Neal Bhatia, MD about the importance of defining the physician-patient relationship, determining when the relationship is established, and understanding the legal implications that come with that fiduciary or heiThe State of Academic Dermatology
https://practicaldermatology.com/topics/practice-management/the-state-of-academic-dermatology/18843/In this edition of Derm Insider, host Neal Bhatia, MD sits down with Jane Grant-Kels, MD, Sheila Fallon Friedlander, MD, and Kevin Cooper, MD to discuss the challenges and rewards of academic dermatology. From meeting aggressive budgets to dealing with EMRs, academicians face many of the same demandValeant Business Update; Melanoma Drugs Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-valeant-business-update-melanoma-drugs-approved/18679/In this edition of DermWireTV from the editors of Practical Dermatology® magazine and DermWire.com, we take a look at Valeant's warning of disruption of dermatology business following its break from specialty pharmacy Philidor. Plus, an update on Melanoma Therapeutics, including approvals of Imlygic